Anaemia in patients with cancer: Role of inflammatory activity on iron metabolism and severity of anaemia

Medical Oncology

Volumn 24, Issue 3, 2007, Pages 323-329

  Jacober, M L V ^a   Mamoni, R L ^a   Lima, C S P ^a   Dos Anjos, B L ^a   Grotto, H Z W ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anaemia of chronic disease; C reactive protein; Cancer; Hepcidin; Inflammation; Interleukins; Iron metabolism

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; IRON; MALE; MIDDLE AGED; NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 36248998247     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-0009-9     Document Type: Article

References (24)

1. Harrison L, et al. Prevalence of anemia in cancer patients undergoing radiation therapy. Semin Oncol 2001;28:54-9.
2. Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol 1998;25:2-6.
3. Weiss G, Goodnough LT. Medical progress: anemia of chronic disease. N Engl J Med 2005;352:1011-23.
4. Clarke H, Pallister CJ. The impact of anaemia on outcome in cancer. Clin Lab Haematol 2005;27:1-13.
5. Nemeth E, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone Hepcidin. J Clin Invest 2004;113:1271-6.
6. Macciò A, et al. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated ovarian cancer: role of inflammation in cancer-related anemia. Blood 2005;106:362-7.
7. Ganz T. Hepcidin - a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005;18:171-82.
8. Means RT Jr. Hepcidin and anaemia. Blood Rev 2004;18:219-25.
9. Dallalio G, Law E, Means RT Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006;107:2701-4.
10. Hinzmann R. Iron metabolism, iron deficiency and anaemia. Sysmex J Internat 2003;13:65-74.
11. Theurl I, et al. Dysregulated monocytes iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 2006;107:4142-8.
12. Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 2005;11:14-23.
13. Sweeney PJ, et al. Effect of subcutaneous recombinant human erythropoetin in cancer patients receiving radiotherapy: final report of a randomised, open-labelled, phase II trials. Br J Cancer 1998;77:1996-2002.
14. Bokemeyer C, Foubert J. Anemia impact and management: focus on patients needs and the use of erythropoietic agents. Semin Oncol 2004;31:4-11.
15. Noronha JFA, Grotto HZW. Measurement of reticulocyte and red blood cell indices in patients with iron deficiency and β-thalassemia minor. Clin Chem Lab Med 2005;43:195-7.
16. Fuchs D, Zangerle R, Denz H, Wachter H. Inhibitory cytokines in patients with anemia of chronic disorders. Ann NY Acad Sci 1994;718:344-6.
17. Jelkmann W. Proinflammatory cytokins lowering erythropoietin production. J Interferon Cytokine Res 1998;18:555-559.
18. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99:3505-16.
19. Nemeth E, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
20. Nemeth E, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-3.
21. Détivaud L, et al. Hepcidin levels in human are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005;106:746-8.
22. Kulaksiz H, et al. Pro-hepcidin: expression and cell specific localization in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004;53:735-43.
23. Dallalio G, Fleury T, Means RT Jr. Serum Hepcidin in clinical specimens. Br J Haematol 2003;122:996-1000.
24. Brookes MJ, Sharma NK, Tselepis C, Iqbal TH. Serum prohepcidin: measuring active Hepcidin or a non-functional precursor? Gut 2005;54:169-70.